Health

Results: 5065-5076 of 9333

TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy

Today the subscription period in SciBase rights issue begins

Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia

PR Newswire associated0

Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing

PR Newswire associated0

Microtech Announces First Human Case of Implantable Microsensor for Heart Failure

PR Newswire associated0

Designs For Health Inc. Held Liable For Infringement of Kaneka's Ubiquinol Patent

Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca

Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn

Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13

PR Newswire associated0

Safe Life Enters French Market with Strategic Acquisition of D-Sécurité Groupe

PR Newswire associated0

Medit Launches a Mobile App, MEDIT M, to Revolutionize Digital Dental Workflows

Keymed Biosciences Announces Approval Of Stapokibart For The Treatment Of Chronic Rhinosinusitis With Nasal Polyposis